Innovative Medicines Canada statement on proposed pharmacare legislation
Ottawa, February 29, 2024 – Innovative Medicines Canada (IMC) is concerned with the federal government’s intent in Bill C-64, An […]
Put your finger on the pulse of the healthcare industry.
For media inquiries, please contact us at media@imc-mnc.ca or 613-462-5367.
Ottawa, February 29, 2024 – Innovative Medicines Canada (IMC) is concerned with the federal government’s intent in Bill C-64, An […]
23 FEBRUARY 2024, GENEVA – The meeting of global trade ministers at the World Trade Organization’s 13th Ministerial Conference in […]
Ottawa, January 5, 2024 – Innovative Medicines Canada (IMC) is deeply concerned with the U.S. Food and Drug Administration’s (FDA) […]
This article originally appeared in the The Globe and Mail on March 4, 2024. Strong gender representation in workplace leadership helps businesses […]
Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.
This article originally appeared in the Hill Times on February 13, 2024. After a diagnosis, having access to state-of-the-art medicines or treatments […]
Get in touch Please complete the form below, and a representative will be in touch as soon as possible. Departments […]
At Innovative Medicines Canada, we offer sponsorship opportunities to facilitate research, generate awareness, create educational programs, and improve access to innovative medicines.
Sign up to our newsletter to get our latest news and updates.
Browse by topic
Informative content to keep you up to date on the most pressing issues facing our industry.